KIMS: Trading Window Closed from April 1, 2026, for Q4 & FY26 Audited Financial Results
Krishna Institute of Medical Sciences Limited (KIMS) will close its trading window from April 1, 2026. This is for the consideration of audited financial results for the quarter and year ending March 31, 2026. The window will reopen 48 hours after the results are declared.
This is a standard procedural announcement related to insider trading regulations and does not directly impact the company's operations or financial performance. It is a routine disclosure required by SEBI.
The announcement is a routine regulatory disclosure regarding the closure of the trading window for financial results and does not contain any specific financial performance data or forward-looking statements that would indicate a positive or negative sentiment.
Krishna Institute of Medical Sciences Limited (KIMS) has announced the closure of its trading window for directors, designated employees, insiders, and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.
The trading window will be closed from Wednesday, April 1, 2026, up to 48 hours after the announcement and declaration of the audited financial results (standalone and consolidated) for the quarter and year ending March 31, 2026. During this period, no transactions involving the company's securities are permitted for the specified individuals.
The trading window is scheduled to reopen 48 hours after the official announcement of these financial results to the stock exchanges. The company will separately intimate the date of the Board Meeting where these results will be considered.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.